Biotech Stocks to Buy Now

Top Stories

ELEVAI Labs Posts Q3 2023 Earnings, Reports Record Quarterly Revenue

ELEVAI Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported its fiscal 2023 Q3 financial results.…

Read More »
Top Stories

ELEVAI Labs Expands Into European Market With Signing of New Partnership

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with…

Read More »
Biotech

ELEVAI Labs Inks Licensing Deal With Yuva Biosciences to Develop New Topical Skincare Formulations and Aesthetics Products (VIDEO)

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced today the signing of a licensing agreement…

Read More »
Top Stories

Capitalist Countdown: Wealthy VC’s Top 5 Investing News Stories of the Week

Last Updated: Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the…

Read More »
Top Stories

Johnson & Johnson, Drug Distributors Finalize $26 Billion Opioid Settlement

While the COVID-19 Pandemic Has Been Dominating the Headlines for the Last Few Years, There’s Another Long-Standing Public Health Crisis…

Read More »
Back to top button